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Abstract
Resistance to the cytostatic activity of the antimalarial drug chloroquine (CQ) is becoming well understood, however,
resistance to cytocidal effects of CQ is largely unexplored. We find that PfCRT mutations that almost fully recapitulate P.
falciparum cytostatic CQ resistance (CQRCS) as quantified by CQ IC50 shift, account for only 10–20% of cytocidal CQR (CQR
CC)
as quantified by CQ LD50 shift. Quantitative trait loci (QTL) analysis of the progeny of a chloroquine sensitive (CQS; strain
HB3)6chloroquine resistant (CQR; strain Dd2) genetic cross identifies distinct genetic architectures for CQRCS vs CQRCC
phenotypes, including identification of novel interacting chromosomal loci that influence CQ LD50. Candidate genes in
these loci are consistent with a role for autophagy in CQRCC, leading us to directly examine the autophagy pathway in
intraerythrocytic CQR parasites. Indirect immunofluorescence of RBC infected with synchronized CQS vs CQR trophozoite
stage parasites reveals differences in the distribution of the autophagy marker protein PfATG8 coinciding with CQRCC. Taken
together, the data show that an unusual autophagy – like process is either activated or inhibited for intraerythrocytic
trophozoite parasites at LD50 doses (but not IC50 doses) of CQ, that the pathway is altered in CQR P. falciparum, and that it
may contribute along with mutations in PfCRT to confer the CQRCC phenotype.
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Introduction
Resistance to quinoline and antifolate antimalarial drugs, as well
as emerging tolerance to artemisinin – based drugs [1] threatens
the health of over half of the world’s population. Understanding
the molecular details of P. falciparum and P. vivax antimalarial drug
resistance phenomena facilitates surveillance of resistance and
rapid development of more effective treatment. Two approaches
for monitoring antimalarial drug resistance for P. falciparum
malaria are available. One is analysis of clinical data to assess
efficacy of specific treatments, the second is in vitro analysis of
parasite strains or patient isolates to quantify their susceptibility to
specific drugs. With the discovery of key genetic mutations in P.
falciparum that confer resistance to either antifolate [2,3] or
quinoline – based [4] antimalarial drugs, rapid field-based
surveillance of the geographic spread of existing drug resistant
malaria is now possible, as is personalized delivery of second tier
drug therapy to patients infected with a specific drug resistant
strain.
Many antimicrobial drugs are both cytostatic and cytocidal,
including quinoline antimalarial drugs such as CQ [5–7]. That is,
under certain conditions a drug slows the rate of cell growth or
impairs cell division such that the rate of proliferation of a mass
population of the microbe is reduced, and under other conditions
the drug kills the microbial cell. Often, cytocidal (cell kill) activity
requires higher dose of drug, longer drug exposure time, or both.
Cytostatic potency is usually quantified via IC50 values (the dose of
drug at which growth is inhibited by 50% relative to control),
whereas cytocidal potency is quantified via LD50 values (the dose
of drug that kills 50% of a microbial population).
However, to date, all laboratory based quantification of
antimalarial drug potency, and hence quantification of all
antimalarial drug resistance phenomena, has been done with
IC50 values alone. Again, IC50 assays quantify the concentration of
drug required to inhibit proliferation of parasite populations by
50%. Drug IC50 for P. falciparum are typically measured in red
blood cell culture suspensions in the continuous presence of serially
diluted concentrations of the drug. Such quantification has proved
critical for defining the genetics and biochemistry behind
resistance to the cytostatic effects of CQ (CQRCS) [4,8–11] and
for identifying new drug leads with excellent cytostatic potential vs
CQR malaria [12]. It is sometimes assumed that IC50 values
measure the ‘‘cell kill’’ effect of a drug. Although this can be true in
specific cases, in many others this is not the case. Use of IC50
values alone can over-estimate the cytocidal activity of a drug and
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can under-estimate potential parasite survival in the presence of
higher (clinically relevant) levels of the drug. Since laboratory CQ
IC50 are in the 10
29–1028 M range, but peak plasma levels of CQ
in patients are ,1000 times higher (1026–1025 M; see [13–15]),
clarification of these points is essential for fully understanding
CQR.
That is, although the mechanism of CQRCS is becoming clear,
much less is known about resistance to the cytocidal effects of CQ
(CQRCC) (or cytocidal resistance vs any other antimalarial drug
for that matter). This is a critical piece of missing information,
given that parasite survival determines the rate of adaptation to
selection by drugs. Only recently has it been possible to efficiently
and reproducibly quantify LD50 for some antimalarial drugs, and
rapid quantification of LD50 differences for drug sensitive vs drug
resistant parasites are found in only one paper to our knowledge
[6]. Formally, without additional information the ratio of drug
IC50 values for drug sensitive vs drug resistant parasites expresses
the degree of cytostatic resistance, whereas LD50 ratios express the
degree of cytocidal resistance [6].
For any drug (anti-tumor, anti-bacterial, anti-fungal, anti-
parasitic) it is theoretically possible that the molecular mechanisms
controlling cytostatic and cytocidal activities could overlap. If this
is the case, then the molecular mechanisms of resistance to those
two distinct layers of drug pharmacology would also presumably
overlap. In other cases, particularly when significantly different
concentrations of drug are needed to kill the relevant cell vs merely
slow its growth, molecular targets for the two layers of drug activity
may differ, and then the mechanisms of cytostatic vs cytocidal
resistance could be distinct. This has been observed in some
examples of multidrug resistance, for example, overexpression of
P- glycoprotein and other plasma membrane events can be
particularly relevant for antitumor drug cytostatic resistance,
whereas altered induction or regulation of apoptosis (programmed
cell death) is particularly important in antitumor drug cytocidal
resistance [16].
Perhaps relatedly, we recently reported that although decreased
CQ accumulation within CQR P. falciparum is clearly related to
elevated CQ IC50, it is not necessarily relevant for elevated CQ
LD50 [17]. Surprisingly, much higher concentrations of CQ or
fluorescent NBD - CQ can be found within parasites exhibiting
cytocidal CQ resistance, even though reduced drug uptake is
generally accepted to be the principle basis of CQR [17]. We have
also recently found that, for both 4 amino quinolines similar to CQ
and quinoline methanols similar to quinine (QN), IC50 is
correlated with the ability of the drugs to inhibit hemozoin
crystallization under close to physiologic conditions, but LD50 for
the same drugs is not [18,19]. Patterns of IC50 vs LD50 for a
variety of quinoline drugs also suggest that the mechanisms for
cytostatic vs cytocidal CQ resistance in P. falciparum are not
entirely the same [6]. Taken together these data suggest that the
cellular targets relevant for quinoline antimalarial drug cytocidal
activities may differ from targets for cytostatic activities. Drug DV
localization and drug/heme binding is the likely basis of CQ
cytostatic pharmacology, but perhaps not the entire basis of CQ
cytocidal pharmacology [17–19]. Since drug resistance is due to
disruption of drug/drug target interactions, then different targets
for cytostatic vs cytocidal effects predict distinct mechanisms of
cytostatic vs cytocidal resistance, unless resistance is merely due to
increased catabolism of the drug (which is not the case for CQR or
QNR in P. falciparum).
With respect to P. falciparum CQRCS, elevated CQ IC50 and
reduced parasite CQ accumulation are well correlated with
mutations in the DV membrane CQ transporter PfCRT [11],
suggesting that CQRCS is due to decreased drug accessibility to
heme targets within the parasite DV [20]. However, resistance to
the cytocidal effects of CQ is predicted to include alterations in
additional targets, access to these additional targets [17], and/or to
encompass mutations in key regulators of P. falciparum cell death
pathways as recently hypothesized [21]. With regard to this last
point, being a single celled organism, and due to the lack of
caspase genes and other genes that encode key apoptosis regulators
within the P. falciparum genome, it is questionable whether the
canonical apoptosis pathway is the cause of drug - induced cell
death for the malarial parasite [21]. Some evidence for an
apoptotic - like cell death pathway for P. falciparum involving
metacaspases has been presented [22–25] but there is disagree-
ment on how relevant these observations are for P. falciparum death
via different drugs [26]. More importantly, no molecular
alterations in apoptosis have been found for CQR malaria.
These points led us to rank the progeny of the HB3 (CQS)6
Dd2 (CQR) P. falciparum cross for CQ LD50 and to perform LD50–
directed QTL analysis. Progeny of this genetic cross have proven
invaluable to analysis of CQR phenomena [4,8,10,27]. By
quantifying CQ IC50 values for these progeny, a single locus on
chr7 was previously identified as controlling the difference
between CQR and CQS strain CQ IC50 [4]. Subsequent
sequencing, in vitro drug pressure, and transfection results showed
that multiple amino acid substitution mutations within a single
gene in the chr7 locus, pfcrt, causes the large shift in IC50 values
that has historically defined CQR and CQS status [4,28,29].
Allelic exchange experiments that directly replaced the ‘‘wild
type’’ CQS associated pfcrt allele with mutant CQR associated pfcrt
resulted in elevated CQ IC50 without the need to condition or
select cells with CQ [30]. The degree to which CQ IC50 was
elevated for these allelic exchange transfectants was very similar to
that seen for highly drug selected CQR strains (70%–90% of the
corresponding strain IC50 shift, see [30]), suggesting that the
presence of mutant PfCRT protein was in-and-of-itself sufficient
(or nearly sufficient) for conversion to a CQR phenotype.
However, subsequent QTL analyses suggested that additional
genetic components, such as inheritance of different chr5 loci
containing mutations and varying copies of pfmdr1, may combine
with PfCRT mutations in various isolates to confer the range of
CQ IC50 and variable IC50 patterns for different drugs now known
to exist across the globe [8–10,27]. In contrast, QTL analysis in
this paper shows a complete lack of the key chr5 locus previously
identified for CQRCS, and identifies additional and unique
genomic loci specific to CQRCC. Examination of genes in these
loci suggests candidate pathways that may contribute to CQRCC.
Relatedly, LD50 analysis of pfcrt allelic exchange progeny further
supports our overall conclusion that although some PfCRT
mutations in and of themselves confer nearly complete resistance
to CQ cytostatic effects as defined by IC50 shift (see [30]), they are
less important for cytocidal CQ resistance (CQRCC) as defined by
LD50 shift. Using antibodies to the autophagy indicator protein
ATG8 and high - resolution fluorescence microscopy, we find that
a drug-induced autophagy-like cascade is dysregulated in CQRCC
P. falciparum. Taken together, and considered alongside additional
recent work with the related parasite T. gondii [31], our data
suggest that a dysregulated autophagy-like process, combined with
PfCRT mutations, promotes elevated CQ LD50 in CQR P.
falciparum.
Materials and Methods
Cell Culture
P. falciparum strains HB3, Dd2, and their genetic cross progeny
were acquired from the Malaria Research and Reference Reagent
Cytocidal Chloroquine Resistance in P. falciparum
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Resource Center (Manassas, VA), while GC03 transfectants (see
[30]) were a kind gift from DA Fidock (Columbia University, New
York, NY). All cultures were grown in complete media at 37uC as
described [6] using type O+ human blood and human serum.
Parasites were highly synchronized 3 times prior to experiments at
0, 10, and 52 hours using a solution of 5% sorbitol as described
[7]. Parasites were incubated at 37uC/5%CO2 in either complete,
starvation, or CQ containing media for 6 hours. When quanti-
fication of PfATG8 puncta was desired, CQ pulse was done for 6
hours using highly synchronized parasites at the mid trophozoite
stage, followed by washing to remove drug as described [6].
IC50 and LD50 Quantification
Our assay for IC50 has been published previously [32] and has
been used extensively and validated by many other laboratories.
Our semi-high-throughput assay for LD50 quantification has
recently been published elsewhere [6]. In brief, for LD50
quantification asynchronous P. falciparum cultures at 2% hemato-
crit and 2% parasitemia were treated with CQ in bolus fashion for
6 hr and then the drug was completely washed away [6]. After
48 hr of further incubation at 37uC under 5% CO2, Sybr Green I
was added and fluorescence was measured at excitation and
emission wavelengths of 485 nm and 538 nm, respectively [6]. For
IC50 quantification initial parasitemia is reduced to 0.5% and cells
remain in the constant presence of lower levels of drug [32]. In
previous work [6] we defined differences in LD50 for synchronized
vs asynchronous culture and vs other variables. LD50 and IC50
data for individual assays (each assay performed with triplicate
plating of parasites treated at a given dose) were fit to a sigmoidal
function using SigmaPlot 9.0 (San Jose, CA), and IC50 or LD50
values were calculated from at least three individual assays (at least
9 determinations in total) and averaged. Outgrowth in the LD50
assay 48 hr after drug is washed away represents expansion of live
cells that survived cytocidal doseages of drug, as supported by
staining for outgrowth after different incubation times (see [6] for
detailed discussion of this point and related issues). CQ IC50 and
LD50 values for laboratory strains analyzed in this paper are found
in Table 1, and CQ LD50 values for HB36Dd2 cross progeny can
be found in Table S1.
QTL Analysis
Using mean LD50 for each of the progeny of the HB36Dd2
cross, genome-wide scans were run using Pseudomarker 2.04 to
detect quantitative trait loci (QTL) associated with the drug
response. Genome-wide significance thresholds which correct for
multiple testing errors were determined by permutation testing
(n = 1000 permutations). The strength of the association between a
given locus and the trait (LD50) is expressed as a logarithm of odds
(LOD) score. Loci that exceeded the 99th percentile (p,0.01), the
95th percentile (p,0.05), and the 37th percentile (p,0.63) were
identified respectively as highly significant, significant, and
suggestive QTL. Two-dimensional linear regression genome scans
were run to test for potential loci interactions and joint LOD
scores were calculated to identify significance interactions.
Candidate genes within QTL loci were selected as described
[33]. In brief, candidate genes were selected based on four
selection criteria: (1) genomic position, (2) structural polymor-
phisms, (3) correlation between LD50 and expression phenotypes
for each parasite, and (4) gene annotations and enrichment
analysis. PlasmoDB version 9.3 was used for SNP density scoring
(CDS), and gene annotations. Gene enrichment analysis for
biological processes and molecular functions was performed using
DAVID [34]. Expression phenotypes for genes within our loci
were taken from [35]. Permutation testing (n = 1000) confirmed
significance of GO enriched terms within the loci of interest.
Preparation of Affinity Purified ATG8 IgG and ATG8
Monoclonal Antibody 2K19
A RACE validated cDNA encoding Toxoplasma gondii TgATG8
(Toxo.DB accession number TGGT1_003400) was used as
template to amplify the full length coding region using the primers
(CACCATGCCATCGATTCGCGACGAAGTGTCC and
TTACCCCAGAGTGTTCTCTGAAGAGTATTCCA
CGTACA). The amplicon was subcloned into pET100 establish-
ing an in frame N-terminal hexa-His tag. Following expression in
E. coli, the recombinant His-TgATG8 was purified on Ni-NTA
magnetic beads (Invitrogen) and used as the immunogen to
immunize a single rabbit (Cocalico, Reamstown, PA). The
resulting antiserum was affinity purified using the bead immobi-
lized crosslinked antigen and eluted using low pH.
Generation of a monoclonal antibody was contracted to
AbMART.com (Shanghai, China) and accomplished using a
synthetic polyprotein containing 6 tandemly arrayed epitopes.
Epitopes were selected on the basis of the highest homology
between TgATG8 and PfATG8. Supernatants from clones
yielding .3 fold signal in an ELISA at 1:128K dilution were
screened by IFA on both Toxoplasma and Plasmodium. Multiple
clones recognizing the epitope HRIRAKYPNR in Toxoplasma
(HKIRSKYPNR in Plasmodium) gave excellent reactivity in both
organisms. The clone 2K19 was selected for detailed work as it
was found to be an IgG1 isotype (data not shown) and gave the
best defined signal in both organisms.
Immunohistochemistry
For starvation treatments, cells at the mid trophozoite stage
were pelleted and resuspended in HBS supplemented with 0.1 mg
mL21 hypoxanthine, 25 mM HEPES (pH 7.3), and 20 mM
sodium bicarbonate. Cells were gassed and incubated at 37uC
for a desired interval (typically 6 hours) before fixation. For CQ
treatments, highly synchronized mid stage trophozoites were
treated as described [6,7] using drug concentrations noted in the
text. Resultant cell pellets were resuspended in complete media
and treated as below.
Table 1. Average CQ IC50 and CQ LD50 (+/2 [S.E.M.]; at least 3
separate assays in each case, each assay done in triplicate for
$9 determinations each) for strains GC03 (CQS), Dd2 (CQR),
7G8 (CQR), C2GC03 (control CQS transfectant), C4Dd2 (CQS
strain GC03 after allelic exchange with CQR Dd2 pfcrt allele),
and C67G8 (CQS strain GC03 after allelic exchange with CQR
7G8 pfcrt allele).
Strain CQ IC50 (nM +/2 [SEM]) CQ LD50 (mM +/2 [SEM])
GC03 22.1 [1.7] .0531 [0.005]
Dd2 206 [26.3] 15.7 [1.82]
7G8 161 [14.1] 3.99 [0.62]
C2GC03 24.4 [1.9] .096 [.008]
C4Dd2 187 [21.0] (90%) 1.10 [0.082] (7%)
C67G8 128 [12.8] (79%) 0.91 [0.067] (23%)
Also shown for C4Dd2 and C67G8 are (% IC50 or % LD50, relative to Dd2 or 7G8
values, respectively). See [30] for description of the allelic exchange
transfectants. Note IC50 assays are done in the continuous presence of low dose
CQ for .48 hrs [33] whereas LD50 assays require higher doses of CQ given as a
6 hr bolus [6].
doi:10.1371/journal.pone.0079059.t001
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Cells were washed 3 times with 25 mM HEPES pH 7.3, fixed
with 4% formaldehyde/0.0075% glutaraldehyde in PBS for 30
minutes, permeabilized with 0.1% Triton X-100 for 10 minutes,
reduced with 0.3 mg mL21 sodium triacetoxyborohydride for 10
minutes, blocked with 5% goat serum for 1 hour, and sequentially
treated with antibodies (1:500) diluted in 5% goat serum/PBS
Tween-20 with PBS washes in between; antibody treatments lasted
1 hour at 37uC in the dark. For experiments involving mouse
monoclonal 2K19, the primary antibody solution was prepared at
1:500 and the secondary (typically goat anti mouse DyLight488) at
1:500. For experiments involving antisera or purified IgG from rat
or rabbit, primary solutions were prepared at 1:500 and secondary
solutions (goat anti rat AlexaFluor594 and goat anti rabbit
DyLight488 or DyLight649) at 1:500. Cells were attached to
#1.5 coverslips and mounted using ‘‘Fluorogel’’ mounting media.
Samples were imaged using a customized Perkin – Elmer spinning
disk confocal microscope with 405 and 491 nm laser lines,
typically at 200 ms exposure and 35% laser power [36].
Cell Fluorescence Data Analysis
Images were iteratively deconvolved using a point spread
function obtained under identical imaging conditions (via doping
one sample with fluorescent beads) and running multiple iterations
in AutoQuantX2 [36]. Images were further processed and
overlayed using Imaris 7.4.2 software. Using the ‘‘spots’’ routine
in Imaris 7.4.2, puncta were defined and distances were measured
from each spot to a single point within the DV as defined by the
center of hemozoin optical density (see [36] and Scheme S1).
These distances were exported to Excel and the resulting data
were plotted as number of puncta vs distance from hemozoin.
Western Blot
Western blots were done as previously described [7] with slight
modification. Fractionation of synchronized iRBC was as
described [7]. SDS-PAGE gels (15% acrylamide) were pre loaded
with lysed trophozoite-infected RBCs, electrophoresed and
transferred to nitrocellulose over night at 4uC. Blots were blocked
with 10% dry milk (Biorad)/PBS, washed63 with PBS/0.1%
Tween-20, labeled with rabbit anti-ATG8 antiserum (1:10,000),
washed again, and incubated with anti-rabbit HRP secondary
antibody (1:5000).
Results
Using a more rapid SybrGreen assay [32] in place of traditional
3H-hypoxanthine incorporation, our quantification of CQ IC50 for
pfcrt transfectants agrees with that published previously (Table 1).
Clones C4Dd2 and C67G8 [30] show approximately 8– fold and 6–
fold shifted CQ IC50, relative to control transfectants (C2
GC03) or
the parental CQS strain GCO3 (Table 1; e.g. 187 nM/24 nM,
C4Dd2 vs C2GCO3). That is, cytostatic CQ resistance for these
clones is very close to that seen for laboratory strains Dd2 and 7G8
as noted earlier [30], suggesting that the Dd2 mutant PfCRT
isoform and the 7G8 mutant PfCRT isoform are necessary and
sufficient (or nearly sufficient) for the IC50 quantified CQR
phenotypes in these widely studied drug selected strains. As
hypothesized previously [30], it is perhaps possible that somewhat
lower expression of PfCRT in the allelic exchange transfectants
relative to the laboratory strains might be responsible for the
measured IC50 shifts of 80% –90% of that observed in strains Dd2
and 7G8 (Table 1 and see also [37]).
Regardless, recently we showed that when expressed as a ratio
of LD50 (dose required to kill 50% of parasites), ‘‘cytocidal’’ CQR
was not the same as ‘‘cytostatic’’ CQR defined by IC50 ratios [6].
When CQ LD50 are quantified for CQR clones C4
Dd2 and C67G8
as described [6] and the ratio vs control clone C2GCO3 calculated,
we find that these clones are 10– fold and 8– fold cytocidal CQR
(‘‘CQRCC’’), whereas strains Dd2 and 7G8 are 130– fold and 35–
fold CQRCC, respectively (Table 1 and see also [6]). That is, in
contrast to exhibiting 80%–90% of the CQ IC50 shifts, the allelic
exchange transfectants exhibit only 7%–23% of the CQ LD50
shifts for laboratory strains harboring the same PfCRT mutant
isoform (Table 1). This indicates that although mutant PfCRT
protein is indeed responsible for most of the CQRCS phenotype
(measured by CQ IC50), it makes a smaller contribution to the
CQRCC phenotype (measured by CQ LD50) observed in the same
strains.
Thus, we leveraged a QTL mapping approach within an
available genetic cross to compare genetic profiles of the two
phenotypes and to search for additional genetic loci contributing
to CQRCC. We quantified CQ LD50 for progeny of the HB3
(CQS) 6 Dd2 (CQR) cross using our recently described high
throughput assay ([6]; see Table S1 for CQ LD50 values). We were
able to identify three major QTL loci associated with LD50. First,
similar to CQ IC50– directed QTL [4] the chr7 locus harboring
pfcrt segregates with the elevated LD50 phenotype (not shown, see
[4]). The LOD score (,21) is lower than the LOD score when
IC50 is the measured phenotype (,40; see [4,10]). We emphasize
that the magnitude of the LOD score reveals how well a locus
segregates with a phenotype across a given population (in this case,
progeny from the HB3 6 Dd2 cross), but does not define the
relative biochemical contribution of proteins encoded by that locus
to the phenotype in question. Behavior of pfcrt transfectants that
isolate PfCRT mutations in a common genetic background shows
that the biochemical contribution of mutant PfCRT to elevated
CQ LD50 is lower relative to its contribution to elevated CQ IC50
(Table 1), nonetheless, PfCRT mutations remain a prominent
contribution to the mechanism of elevated LD50.
Second, two new chromosomal loci, not previously associated
with any CQR phenomena, are associated with elevated CQ LD50
in CQR progeny of the HB36Dd2 cross (Fig. 1). One is a novel
contribution from chr6 (0 cM –17.3 cM) that can increase CQ
LD50 for CQR progeny of the cross (Fig. 1B). Furthermore, this
locus interacts with chr8 (77.5 cM) with significant additive effects
(Fig. 1E). In addition to defining a genetic architecture for CQ
LD50 that is distinct from that previously defined for CQ IC50
(Fig. 1C), the loci contain genes that may contribute to CQRCC
but that are not involved in CQRCS. In contrast, QTL scans of
IC50 for the same CQR progeny identify a segment of chr5
(carrying the pfmdr1 amplicon) as contributing to elevated IC50
(Fig. 1A, [10]), and as described previously [10], pairwise
interaction between the chr5 segment and the chr7 locus is
associated with elevated IC50 in the CQR progeny (Fig. 1D).
Results from many studies show that the relevant gene in this
segment of chr5 is likely pfmdr1 [38–41]. However, importantly,
LD50 - directed QTL analysis does not identify this chr5 fragment
(Fig. 1C) or the chr56chr7 pairwise interaction. Instead, it isolates
a fragment of chr6 (Fig. 1B), and defines a chr66 chr8 pairwise
interaction relevant for elevated LD50 (Fig. 1E). In sum, these data
force us to conclude that the LD50 and IC50 phenotypes share a
critical feature (mutant PfCRT found on chr7) but are otherwise
genetically distinct.
Our interpretation is that the CQRCC and CQRCS mechanisms
overlap (each requires mutant PfCRT), but that the relative
contribution of PfCRT to CQRCC is less than, or mechanistically
distinct from, its contribution to CQRCS (Table 1) and that high
level CQRCC requires additional factors (Fig. 1B, 1E). The
question then becomes how might genes in chr7, chr6, and chr8
Cytocidal Chloroquine Resistance in P. falciparum
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Figure 1. LD50 vs IC50 directed QTL analyses for CQR HB36Dd2 cross progeny. A) IC50 QTL scan for CQR progeny shows a peak on chr5
(asterix) that encompasses pfmdr1 as previously described [10]. Notably, the chr6 locus that is pertinent for the LD50 scan (see Fig. 1B) does not pass
the suggestive threshold on this IC50 scan. B) LD50 QTL scan for CQR progeny shows a peak on chr6 (asterix; L.O.D. = 2.5, passing the suggestive
threshold). The locus that includes pfmdr1 does not pass the suggestive threshold for this scan (see also Fig. 1C). C) To more clearly highlight the
differences in genetic architecture for LD50 vs IC50 phenotypes, an overlay of the two QTL scans is shown. The CQR progeny LD50 QTL scan is shown in
blue, while the CQR progeny IC50 QTL scan is in black. The overlay shows quite clearly that the pfmdr1 locus does not factor at all into the LD50
phenotype, and that the chr6 locus does not factor at all into the IC50 phenotype. Thus the IC50 and LD50 phenotypes are genetically distinct. D)
Similarly, the interaction locus between chr6 & 8 (see text) does not appear on a IC50 pair-wise scan. However, additive effects between chr5 and chr7
loci are seen, as previously reported [10]. E) Pair-wise scan of the CQR progeny shows that chr6 and chr8 loci (circle) have additive effects on LD50
(L.O.D. = 4.3).
doi:10.1371/journal.pone.0079059.g001
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loci act together to elevate CQ LD50 up to 250 fold (Table S1;
note CQ LD50 = 32 mM for 3BA6), when Dd2 mutant PfCRT in
and of itself only appears to elevate CQ LD50 10 fold (Table 1)?
Inspection of the chr6 and chr8 loci reveals multiple genes
involved in processes linked to ‘‘vesicle traffic’’, ‘‘proteasome
function/proteolysis’’ and ‘‘lipid metabolism’’ (Table S2 & S3).
For example, at least 6 genes within the chr8 locus encode proteins
putatively involved in the proteasome pathway (Table S3).
Candidate genes were also ranked based on the sequence
similarity of strain HB3 (CQS) and strain Dd2 (CQR), and the
correlation of expression levels with the LD50 phenotype (see
Tables S2 & S3). Thus we used four previously vetted methods
[33] to identify genes or pathways that are most likely relevant to
LD50. Interesting genes within the chr6 and chr8 loci that have
high CDS scores include putative orthologues of autophagy genes
ATG11 and ATG14, several key metabolic regulators, multiple
kinases, and a putative E3 ubiquitin ligase (Table S2 & S3). Also of
note are several genes in the chr6 locus linked to response to
oxidative stress. Due to the nature of chromosomal fragment
inheritances in the HB3 6Dd2 cross, the chr6 6 chr8 additive
effect defines a much smaller region of the chr6 segment. This
segment harbors only 20 genes, with 7 of those encoding proteins
involved in lipid metabolism (see Discussion).
Elevated LD50 indicates resistance to cell death. Cell death is
often mediated by signal transduction that controls a programmed
cell death (PCD) pathway [21]. Importantly then, we find that the
chr6 and chr8 loci do not harbor any candidate Pf metacaspases
[23] or other molecules that typically regulate apoptotic PCD.
That is, we find no genetic evidence from the HB36Dd2 cross for
atypical apoptosis related to CQRCC. Autophagy (‘‘self eating’’
upon starvation or stress) is an alternate pathway that has been
linked to cell death for several cell types [42–44], including the
related apicomplexan parasite T. gondii [31,45]. It is an orches-
trated, vesicle mediated, proteolysis/degradative pathway that is
distinct from apoptosis. Since apoptosis genes were not found in
chr6 or chr8 loci, and since ‘‘vesicle traffic’’, ‘‘proteasome/
proteolysis’’, ‘‘lipid metabolism’’, ‘‘oxidative stress’’ and autophagy
pathways often overlap mechanistically (see Discussion), we
wondered if altered autophagy might be related to LD50.
However, no experiments to our knowledge have been done to
test if autophagy occurs in intraerythrocytic P. falciparum. The
universal stimulus for autophagy is starvation, which also
unambiguously induces cell death. An unambiguous feature of
induction of autophagy in eukaryotes is redistribution of ATG8
protein (called LcIII in mammals) from a more localized and
diffuse pattern to a more widely disbursed, more punctate pattern
that defines the sites of autophagosome formation and/or
recruitment of autophagosomal ‘‘cargo’’ [46]. Specific ATG8
antisera raised vs. T. gondii ATG8 protein (anti TgATG8) show
excellent cross reactivity vs P. falciparum ATG8 because PfATG8 is
,70% identical to TgATG8 [21]. We easily identify a PfATG8
doublet at predicted masses of 15 & 17 kDa in immunoblots of
fractionated parasites (Fig. 2D) that is consistent with well known
de-lipidated and lipidated forms of ATG8 [46]. IFA analysis using
ATG8 antiserum suggests an autophagy-like process is active in
intraerythrocytic P. falciparum trophozoites (Fig. 2,3). As expected,
control iRBC trophozoite parasites grown in complete media show
a cytosolic PfATG8 distribution (Fig. 2A, green) that appears
somewhat punctate, perhaps due to at least partial localization to
the apicoplast (see below and [47]). However, notably, when
highly synchronized trophozoites are placed in starvation medium
for 6 hrs, PfATG8 is redistributed in a much more expanded
punctate fashion (Fig. 2B, green), as recently reported [21]. Closer
inspection reveals puncta at the parasite periphery, possibly near
the RBC membrane. Co – staining with a marker for Maurer’s
cleft (anti - PfREX1, red) shows that some PfATG8 appears to be
routed to very near Maurer’s cleft (MC) (yellow dots, Fig. 2B
middle). The well - characterized inhibitor of autophagy, 3-methyl
adenine (3-MA) partially reverses the starvation induced PfATG8
puncta redistribution (Fig. 2C), similar to what has recently been
found for T. gondii [31]. Affinity purified IgG from the antisera as
well as monoclonal antibody 2K19 raised against a highly
conserved Apicomplexan ATG8 motif (see methods) yield results
similar to polyclonal TgATG8 antisera (Fig. 3). Another recent
report [47] presents data consistent with some localization of
PfATG8 to the parasite apicoplast for control schizonts growing in
normal media. We also obtain data consistent with partial (but not
exclusive) localization of PfATG8 to the apicoplast for control late
trophozoites/early schizonts, by co – staining for apicoplast –
specific PfACP protein (see Fig. S1). We note that the trophozoite
(feeding) and schizont (nuclear division/parasite replication) stages
of parasite development would be expected to utilize autophagy
machinery in different ways [48,49] and that further study of
PfATG8 in trophozoites vs schizonts is warranted.
We next tested if cytocidal levels of CQ induced similar
PfATG8 redistribution. Indeed, CQS parasites show similar
extensively distributed PfATG8 puncta when they are treated at
26LD50 cytocidal dose of CQ (Fig. 4A), but not when they are
treated with 26IC50 cytostatic dose (Fig. S2). Thus the autophagy
– like cascade induced by starvation is also involved in the
response to cytocidal levels of CQ, but not response to cytostatic
levels. When CQR parasites are treated with the same absolute
dose (26CQS LD50 dose; 250 nM), we do not observe the
punctate redistribution of PfATG8 (see below). However, when
CQR parasites are treated with 26CQR parasite LD50 dose (e.g. a
similar effective pharmacologic dose, ,32 mM for strain Dd2, see
[6]) some PfATG8 redistribution is observed (Fig. 4B), but the
ATG8 response appears somewhat muted.
To quantify this behavior, we devised a method based on
spinning disk confocal microscopy and 3D Imaris rendering of z
stacks to plot radial distributions of PfATG8 puncta relative to
hemozoin optical density (Fig. 5). Essentially, very optically dense
hemozoin within the DV is used to define a ‘‘center’’ point of
reference for the iRBC parasite (Fig. 5 left) and distinct, clearly
defined spots of ATG8 fluorescence (Fig. 5 middle, see also
Scheme S1) are then measured for their relative distance (x,y,z)
from the center of hemozoin optical density (white lines, Fig. 5
right). Using these methods, we quantified PfATG8 puncta
abundance at .3.5 mm for CQS HB3, CQR Dd2 and C4Dd2
parasites +/2 starvation and across a range of bolus CQ dosages
(Fig. 6). These puncta distributions show that starvation produces
similar number and similar radially distributed patterns of
peripheral PfATG8 puncta for CQS and CQR parasites (compare
far left and far right bars in each panel Fig. 6), but that 26CQS
LD50 dose of CQ (250 nM) only produces high numbers of distal
radially - distributed puncta for CQS strain HB3 (Fig. 6A top), not
for CQR strain Dd2 (Fig. 6B middle). C4Dd2 transfectants,
wherein CQR is mediated solely by allelic exchange with CQR
associated mutant pfcrt, show PfATG8 behavior that is interme-
diate relative to CQS HB3 and CQR Dd2 (Fig. 6C bottom), and
again, Dd2 shows a muted ATG8 response (hashed bars indicate
26LD50 dose for each strain).
We further tested the association between peripherally distrib-
uted PfATG8– positive puncta and CQR status by examining 4
other well-characterized strains, two CQS (strains 3D7 and Sudan
106) and two CQR (strains FCB and 7G8). Upon starvation for
6 hr, all 4 strains distribute PfATG8– positive puncta in a
peripheral fashion similar to starved HB3, Dd2, and C4Dd2
Cytocidal Chloroquine Resistance in P. falciparum
PLOS ONE | www.plosone.org 6 November 2013 | Volume 8 | Issue 11 | e79059
Figure 2. PfATG8– positive puncta. Shown are puncta for (A) control HB3 iRBC grown under normal culture conditions (B) HB3 iRBC grown for 6
hours under starvation conditions (see Methods) and (C) HB3 iRBC grown under starvation conditions plus the autophagy inhibitor 3 methyl adenine
(3 MA). Shown are transmittance (left), immunofluorescence vs antiPfREX1 (Maurer’s cleft marker; red; second column), immunofluorescence vs
antiTgATG8 (cross reacts with PfATG8; green, third column) and overlays (right). Bar = 5 mm. Also shown (D) are western blot data for iRBC harboring
HB3 (CQS) and Dd2 (CQR) trophozoites grown under control culture conditions. Two separate gels for two independent sets of samples (two iRBC
isolations for each culture) are shown. We note our data show a clear doublet at 15 and 17 kDa, similar to all other studies of eukaryotic ATG8 protein
of which we are aware except one [47], which resolves only a single band instead of the usual doublet with a polyclonal antisera raised against a
recombinant GST-PfATG8 fusion. We suggest three possible reasons for the discrepancy: 1) we use higher density [15% acrylate] gels relative to [47]
in order to resolve the low mass doublet, 2) we do not solubilize parasites with saponin as in [47] which would release de - lipidated ATG8 into wash
supernatant, 3) perhaps abundance of one PfATG8 species (presumably de lipidated) is higher in trophozoites relative to schizonts examined in [47].
doi:10.1371/journal.pone.0079059.g002
Figure 3. Comparison of antisera vs monoclonal Ab staining. Shown are results for TgATG8 antisera (bottom row) vs staining using a
monoclonal antibody raised vs a highly conserved Apicomplexan ATG8 epitope (top row, see methods). Panels A,G,D,J are transmittance, B,H,E,K are
ATG8 fluorescence, and C,I,F,L are overlay, respectively. Left side is control intraerythrocytic HB3 P. falciparum; right side is HB3 starved for 6 hrs as
described in methods. Bar = 5 mm.
doi:10.1371/journal.pone.0079059.g003
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Figure 4. PfATG8 (green) re distribution, CQ vs time. CQS (strain HB3; top panel A) and CQR (strain Dd2; bottom panel B) parasites were grown
in control media (left column) or in media plus 26LD50 dose of CQ (250 nM for HB3 Fig. 4A, 30 mM for Dd2, Fig. 4B) for 2, 4 or 8 hrs (column 2,3,4
respectively). The top row in panels A and B is transmittance, the second (green) is staining for PfATG8, the third is DAPI to visualize the single
trophozoite nucleus, and the bottom row for each panel presents the overlay. Fluorescence acquired at 35% power, 200 ms, 642 nm; emission 700/
75 nm dichroic, 690 nm cut-off. Bar = 5 mm.
doi:10.1371/journal.pone.0079059.g004
Cytocidal Chloroquine Resistance in P. falciparum
PLOS ONE | www.plosone.org 8 November 2013 | Volume 8 | Issue 11 | e79059
(Fig. 7). However, as shown in Fig. 7, only the CQR strains show
no increased peripheral puncta at 250 nM CQ (26CQS LD50)
whereas both CQS strains do. Also, even though 26CQR LD50
(32 mM) induces formation of peripheral puncta for the CQR
strains, similar to CQR strain Dd2 (Fig. 6), the numbers are
reduced relative to 26CQS LD50 treated CQS. To summarize,
3 CQR laboratory strains behave similarly, and are distinct from
all 3 CQS strains examined. In terms of statistical significance of
these data, P,0.01 when puncta produced upon 250 nM CQ
exposure for any CQS strain (HB3, 3D7, S106) is compared vs
250 nM CQ puncta data for any CQR strain (Dd2, FCB, 7G8).
However, P values are .0.4 when any two CQR or any two CQS
strains treated with the same dose are compared. That is, no CQR
strains are significantly different from each other, no CQS strains
are significantly different from each other, but all CQR strains
show statistically significant differences in PfATG8 redistribution
vs all CQS strains. This suggests that redistribution of PfATG can
serve as a marker to quantify sensitivity to cytocidal CQ.
We next inventoried sequences of all P. falciparum orthologues
of autophagy pathway proteins that we can identify at this time
(see also [50]) using available genomes, and note that a number
of putative orthologues of key autophagy proteins are mutated
in Dd2 (CQR) vs HB3 and 3D7 (CQS) parasites (see
Discussion). For example, a recently identified P. falciparum
PI3’ kinase (PF3D7_0515300; [51]) appears to us to be a Vps34
orthologue, based on its very high identity to ScVps34 (E-
value = 1610273; homology index score = 567). A similar
conclusion was also reached by Kitamura et al. [47]. During
autophagy in other eukaryotic cells, Vps34 produces copious
PI3P at the developing autophagosome, where ATG8 protein
also localizes. PfVps34 from CQR strain Dd2 shows point
mutations and deletions relative to CQS strains HB3 and 3D7
that could conceivably affect function or regulation, as described
in Discussion. Quite interestingly then, this enzyme has recently
been localized to near Maurer’s cleft organelles [51], very
similar to the PfATG8 relocalization upon starvation that is
reported here. It remains to be determined if these additional
autophagy gene mutations uniformly segregate with CQRCC
phenomena for geographically distinct isolates of CQR P.
falciparum. Importantly, LD50 quantification for these isolates will
need to be performed, which will require the ability to culture
these isolates over long time periods.
Discussion
Data in this paper reveal three important concepts:
1) Mutant PfCRT protein, while responsible for the majority of
the shift in CQ IC50 that has traditionally characterized CQR
P. falciparum strains Dd2 and 7G8 ([30], and present data), is
only responsible for 10–20% of the shift in CQ LD50 for the
same strains of CQR parasites. PfCRT is thought to confer
CQRCS by reducing access of CQ to DV – localized heme
target and thereby reduce the ability of the drug to inhibit
heme – hemozoin biomineralization [11,29]. However, recent
data [17] shows that DV levels of CQ are not necessarily
correlated with CQ LD50. In addition, other recent work
[18,19] shows that the ability of CQ or QN analogues to
inhibit hemozoin formation correlates with their IC50 activity,
but not with their LD50 activity. Thus our observations are
not as surprising as they might initially appear, and one
important implication is that targets in addition to inhibition
of hemozoin crystallization are likely relevant for the cytocidal
activity of quinoline antimalarial drugs.
2) LD50– directed Quantitative trait loci (QTL) analysis in the
well-characterized HB3 6Dd2 genetic cross shows that the
chr5 segment previously identified as modulating PfCRT
mediated CQRCS does not contribute to CQRCC. Other
distinct differences in genetic architecture include two novel
loci, on chr6 and chr8, associated with elevated LD50. These
loci are enriched for genes that encode proteins linked to
proteosome and autophagy pathways, but no genes encoding
metacaspases or other proteins that regulate apoptosis are
found in the loci (Tables S2– S7). A number of recent
observations suggest interesting cross talk between proteasome
and autophagy pathways (e.g. [52,53]), thus enrichment for
both processes in the LD50 loci is intriguing.
3) Staining for a definitive marker of autophagy (ATG8 protein
puncta) shows cell death from LD50 CQ treatment is linked to
an autophagy – like process and that this process is altered in
CQR parasites. Interestingly, we find that starvation and CQ
– induced death lead to accumulation of PfATG8– positive
puncta to near Maurer’s clefts (MC). These poorly understood
organelles are known to be involved in export of proteins from
the parasite to the red cell plasma membrane but they are also
Figure 5. Semi automated computational method for quantifying the distribution of ATG8 puncta relative to hemozoin crystals
within the DV. (A) Hemozoin within the DV is detected by transmittance, the outline of ,10% transmittance is defined (labeled ‘‘DV’’, left panel)
and the center of this outline then defined by voxel analysis using Imaris software. (B) The center of distinct ATG8 puncta (bright green dots) are
labeled using the option ‘Add new measurement points’ in the Imaris ‘‘spots’’ subroutine. (C) Distances from the hemozoin center to the ATG8
puncta centers are then computed (white lines) and data collated in excel.
doi:10.1371/journal.pone.0079059.g005
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believed to have several other functions, including vesicle
fusion [54].
To our knowledge, only three studies have attempted to
distinguish CQ cytostatic and cytocidal activities in vitro [5,6,55]
but only recently have LD50 been quantified [6], allowing QTL
analyses as presented here. All previous cellular quantification of
antimalarial drug resistance phenomena of which we are aware
has been solely via IC50 ratios. IC50 does not a priori define
cytocidal (parasite kill) potency; formally it defines growth
inhibition potency vs mass populations of parasites. It is certainly
true that killing some parasites over time with a drug prevents
growth seen in control cultures, but it can also be true that a drug
in continuous culture does not kill parasites, but merely slows the
cell cycle, changes multiplicity of schizogony, or has other effects
that yield IC50 of a given value for mass populations of parasites
[7]. CQ appears to exhibit both dose dependent (‘‘Cmax’’) ([7] and
this work) and time dependent (‘‘TMIC’’) [56] parasite killing. In
studies that report IC90 data there may be greater ‘‘mixing’’
between CQ cytostatic and cytocidal effects relative to studies that
report IC50 data. In this paper, we have made the first attempt to
our knowledge to more fully separate CQ IC50 and LD50
phenomena for progeny of the HB36Dd2 cross.
We previously found that some strains are much more CQRCC
than CQRCS [6], and that the rank order of LD50 and IC50 for
different drugs varies (meaning the drugs to which a parasite shows
the highest IC50 are not necessarily the drugs to which it shows the
highest LD50 [6]). Plotting CQ IC50 [4] vs CQ LD50 [Table S1]
for HB36Dd2 progeny yields poor correlation (r2,0.4; not
shown). Also, a recent study shows that CQ transport ability for
13 mutant PfCRT isoforms found in 13 different CQR strains
does not correlate with CQ IC50 for those strains [57].
Considering these observations along with the current data
suggests that parasite resistance to cytocidal effects of CQ is
influenced by additional genetic or physiological events, along with
PfCRT mutations. Our initial analysis suggests these events
include alterations in a novel pathway showing some similarities
to autophagy.
In all eukaryotic cell types examined, the re distribution of
ATG8 protein to more widely disbursed puncta marks the
induction of autophagy by starvation [46]. In all other examples,
the membranes to which ATG8 is routed are synthesizing double
membraned autophagosomes and copius phosphatidyl inositol 39
phosphate (PI3P) via Vps34. It is striking then that previous work
completely unrelated to the present study places PfVps34 near
MC, similar to our localization for some re – routed PfATG8 [51].
In all eukaryotic cell types examined, autophagosomes containing
high levels of ATG8 and PI3P lipid then engulf cytosolic or
organellar targets, fuse with lysosomes, and the contents are then
degraded, serving as nutrient pools that temporarily keep the
starving cell alive. In the case of P. falciparum, the parasite
trophozoite undergoes heightened accumulation of PfATG8–
associated vesicles at or near the MC upon starvation and
cytocidal CQ treatment. The parasite trophozoite does not appear
to engulf and degrade its sole mitochondrion to provide additional
food upon starvation. Indeed, starvation induced mitochondrial
fragmentation by autophagy in T. gondii causes cell death [31].
Instead, the unique properties of the RBC, which is devoid of de
novo biosynthetic activity as a host cell, necessitates enhanced
endocytosis to acquire extracellular food. We suggest that under
starvation pressure the parasite up regulates additional endocytosis
from the red cell cytosol using (at least in part) the vesicle
formation and fusion functions of encoded autophagy machinery.
This might be consistent with PfATG8 vesicles eventually
interacting with the parasite DV, analogous to ATG8 positive
vesicle fusion to lysosomes in other eukaryotes after they recruit
nutritional ‘‘cargo’’.
In yeast and higher eukaryotes, membrane association of ATG8
is mediated by lipidation. The terminal G residue of ATG8 that
becomes lipidylated is blocked, necessitating proteolytic cleavage
by ATG4 as a prelude to membrane association [46]. Notably
however, P. falciparum PfATG8 terminates with G, thus ATG4
Figure 6. Quantified PfATG8 puncta distribution for synchro-
nized trophozoite parasites. Shown are CQS HB3 (top) CQR Dd2
(middle) and transfectant C4Dd2 (bottom) under different conditions. Far
left, ‘‘CM’’ = control culture conditions, far right, ‘‘SM’’ = iRBC in
starvation media for 6 hr. In between are puncta quantified for iRBC
treated for 6 hrs with the indicated [CQ]. Black bars in each panel
denote 26IC50 [CQ] for the strain, hashed bars denote 26LD50 [CQ] for
the strain. Data are the average of at least 20 iRBC, +/2 s.d., and puncta
that are $3.5 mm from DV hemozoin optical density are plotted. The
three phenotypes are distinct, as evidenced by statistical comparison of
results upon 250 nM and 3.6 mM treatments common to all three
strains; for 3.6 mM data, HB3 vs Dd2, HB3 vs C4Dd2, and Dd2 vs C4Dd2,
P value ,0.05 in each case. For 250 nM data, HB3 vs Dd2 or HB3 vs
C4Dd2, P value ,0.05, but Dd2 vs C4Dd2.0.05. That is, as proposed in
the text, C4Dd2 is intermediate relative to HB3 and Dd2: both Dd2 and
C4Dd2 differ from HB3, but C4Dd2 shows behavior similar to Dd2 at
lower dose CQ, but different behavior vs Dd2 at higher dose.
doi:10.1371/journal.pone.0079059.g006
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proteolysis to reveal G as in other species is absent, suggestive of
constitutive membrane association [49]. In reality however,
PfATG8 exists in both the unlipidated and lipidated forms
(Fig. 2D) suggesting mechanisms other than ATG4 regulate
PfATG8 dynamics. We propose that a low level of constitutively
activated autophagy is present in iRBC parasites, and that CQR
parasites have developed resistance to CQ induced perturbations
in autophagy. Accumulation of PfATG8 puncta upon toxic CQ
treatment is consistent with either upregulation of puncta
formation or inhibition of autophagosome fusion, so CQR
parasites could in theory have perturbations in either (or both)
steps of the autophagy pathway.
Interestingly then, CQ is a known potent inhibitor of autophagy
in other cell types. Its diprotic weak base character promotes
profound accumulation in acidic compartments such as lysosomes,
autophagosomes, and vacuoles. At doses that correspond to these
LD50 CQ is known to block the fusion of autophagosomes with
lysosomes/vacuoles and also raises the pH of these compartments,
thereby inhibiting processes that require acidic pH (e.g. intra
lysosomal proteolysis ([42,44] and references within)). A few
molecular possibilities specific to P. falciparum are that LD50
dosages of CQ (i) block the fusion of endocytic vesicles carrying
hemoglobin to the DV (in fact, a somewhat overlooked paper [58]
shows that CQ LD50 doses do indeed lead to a buildup of
undigested Hb trapped within arrested parasite vesicles), (ii) inhibit
falcipain and plasmepsin activity by raising the pH in endocytic
vesicles and/or the DV, (iii) inhibit fusion of autophagosomes
and/or other vesicles with their target organelles. Other
lysosomotropic agents would be expected to mimic this CQ
pharmacology. Interestingly then, certain alkaloids that inhibit
autophagy also show antimalarial activity [59,60]. One example is
voacamine, a tertiary alkaloid isolated from Peschiera fuchsiaefolia
stem bark that shows good antimalarial activity (238 ng/mL vs
strain D6 and 290 ng/mL vs strain W2), and which has also been
reported to chemosensitize MDR cancer cells in an autophagy-
dependent manner [61]. Overall, since P. falciparum has been
subjected to decades of cytocidal CQ selective pressure, it is logical
that the parasites would evolve resistance to CQ autophagy
inhibition.
With regard to the starvation effects that we observe, work in
the Goldberg laboratory has shown that P. falciparum meets its
amino acid requirements by a combination of hemoglobin
degradation and uptake of free amino acids from the medium
[62–64]. When some extracellular amino acids are removed, the
parasite responds by up – regulating additional hemoglobin
transport and degradation; hemoglobin, however, lacks the
essential amino acid Ile, so parasite survival is conditional under
these circumstances [63]. Conversely, if the hemoglobin pathway
is inhibited, the parasite survives by acquiring additional amino
acids from the extracellular medium. If Ile is withdrawn the
parasite can enter a hibernatory state [64]. These observations
suggest that (i) malaria parasites are able to sense amino acid levels
Figure 7. Quantified PfATG8 puncta at $3.5 mm from hemozoin for synchronized trophozoites. Two additional CQR and two additional
CQS strains are analyzed. Shown are puncta counts for at least 20 iRBC, +/2 s.d. grown under control conditions (‘‘CM’’, left side each panel), upon
starvation (SM; far right, each panel) and upon dosing for 6 hrs with either 26IC50 or 26LD50 concentrations of CQ (50 nM and 250 nM for CQS
strains, and 250 nM and 32 mM for CQR strains, respectively).
doi:10.1371/journal.pone.0079059.g007
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in the medium and (ii) they possess a system that can respond to
the lack of some extracellular amino acids by regulating
intracellular transport to the vacuole. During starvation induced
autophagy, other eukaryotic cells respond to low amino acid levels
in the medium by trapping cytosolic material in transport vesicles,
which will eventually fuse and release cargo into a lysosome or
vacuole to then be digested to amino acids. Although for
intraerythrocytic P. falciparum the ‘‘cargo’’ is presumably within
the host cell cytosol, starvation induced autophagy reported here
could be somewhat reminiscent of elevated hemoglobin endocy-
tosis in P. falciparum.
We wondered if autophagy genes in the identified chr6/chr8
loci might be hinting at mutations in other Pf autophagy gene
(PfATG gene) orthologues for CQR parasites. A partial inventory
of PfATG gene orthologues has been published [50] but does not
include important co factors such as Vps34, Pex14, Vps15, etc. We
re – queried the Pf genome with a more complete set of 42
autophagy related genes. Remarkably, a number of candidate
orthologues (16 of 42) lie within QTL loci previously associated
with drug resistance phenomena, or within ‘‘eQTL’’ gene sets that
are up/down regulated in trans by resistance associated eQTL
[35]. Also, after alignment of Dd2 (CQR) vs HB3 and 3D7 (CQS)
alleles via Broad Institute data (http://www.broadinstitute.org/),
we find that many candidate PfATG gene orthologues are
mutated in the Dd2 CQR genome relative to 3D7 or HB3
CQS. One in particular is candidate PfVps34 (PF3D7_0515300;
E-value 10273 and homology index score 567 relative to ScVps34)
which encodes K at codon 423 for Dd2 in place of Q found for
HB3 and 3D7, deletion of a N residue found at position 578 for
HB3 and 3D7, and a deletion of 24 codons relative to HB3 and
3D7 (from codon 931 to 955). Interestingly, this deletion is within
what we predict is a C2 regulatory domain that presumably binds
Ca2+; a similar C2 domain prediction for this protein has also been
made by two other groups [51,65]. Since a clear TOR orthologue
is missing within the P. falciparum genome [50] altered regulation
via mutant PfVps34 is one possibility for the altered cascade seen
in CQR strain Dd2.
Regardless, we predict that multiple routes to dysregulated
autophagy will be found for various strains and isolates of CQRCC
P. falciparum, analogous to how multiple routes to dysregulated
programmed cell death are found in various multidrug resistant
tumor cell lines [16]. At LD50 doses, via its well known
lysosomotropic behavior [58,66] CQ will inhibit vesicle formation
and vesicle fusion, two processes that are essential to autophagy.
Since these processes are controlled by a number of proteins,
many mutations are possible for altering CQ response.
In sum, we find that mutant PfCRT protein confers the
majority of CQRCS as defined by CQ IC50 shift, but only partial
CQRCC as defined by LD50 shift. Not surprisingly then, our data
also show that distinct genetic architecture is associated with
CQRCS vs CQRCC, that a specialized P. falciparum autophagy
cascade is induced by LD50 doses of CQ but not IC50 doses of the
drug, and that altered regulation of this unique autophagy – like
process is present in CQRCC parasites. Consistent with a clear role
for autophagy in cell death for other apicomplexa [31,45], altered
PfATG8 redistribution indicative of a novel autophagy – like
cascade appears to be associated with CQRCC for intraerythro-
cytic P. falciparum trophozoites. Elucidating additional molecular
events controlling perturbation of autophagy signaling for CQR P.
falciparum, potentially involving at least two dozen autophagy gene
orthologues [50], should prove to be a fertile area of future
research. Among additional data needed to elucidate the pathway
further are precise measurements of ATG8 puncta flux, meaning
the rate of ATG8 vesicle production vs presumed fusion with
either MC and perhaps the DV.
Finally, regardless the exact role of the novel autophagy – like
process for iRBC trophozoites that we describe here, we propose
that CQRCC requires prior acquisition of CQRCS, meaning that
parasites must first be able to survive lower IC50 dose via PfCRT
mutations, before they can survive higher LD50 dose via acquiring
additional autophagy mutations. Precise measurements of IC50 vs
LD50 phenomena among geographically diverse isolates of CQR
P. falciparum will further test this hypothesis. Also, since PvCRT
mutations have not been found for CQR P. vivax, it should prove
interesting to investigate the status of genes in the chr6 and chr8
loci for CQR P. vivax isolates, as well as the formation of PvATG8
positive structures in response to CQ treatment.
Supporting Information
Figure S1 Late trophozoite/early schizont stained with
anti-ATG8 (green) and anti-apicoplast (red) antibodies.
Some overlap between ATG8 and apicoplast localized ACP (D)
suggests partial (but not complete, ,25%) co – localization of
PfATG8 and apicoplast as previously suggested [46]. Scale
bar = 5 mm.
(DOC)
Figure S2 CQS (HB3, A) and CQR (Dd2, B) parasites
treated with IC50 (top row each panel) and 26 IC50
(bottom row) doses of CQ (10, 20 nM and 125, 250 nM,
respectively) for 48 hr. Parasites were then stained for ATG8
(green) and with DAPI (blue), as described in Methods. Very few
peripherally disposed PfATG8 puncta are observed, supporting
the conclusion that puncta formation is associated with LD50, but
not IC50 doses of CQ. Scale bar = 5 mm.
(DOC)
Table S1 LD50 values for the HB36Dd2 cross progeny.
(DOC)
Table S2 All genes within the chr6 LD50 locus.
(DOC)
Table S3 All genes within the LD50 chr66chr8 interac-
tion.
(DOC)
Table S4 GO enriched molecular functions for the chr6
LD50 locus.
(DOC)
Table S5 GO enriched biological processes for the LD50
chr6 locus.
(DOC)
Table S6 GO enriched molecular functions for the LD50
chr66chr8 interaction.
(DOC)
Table S7 GO enriched biological processes for the LD50
chr66chr8 interaction.
(DOC)
Scheme S1 Cartoon representation of 3D puncta quan-
tification method used in the present work. Hemozoin
density (red ‘‘x’’) is used as the origin, and distances toPfATG8
positive puncta are defined for the reconstructed confocal z stack
of images, relative to hemozoin, using 3D Cartesian (x,y,z)
coordinates. The cartoon shows an abbreviated depiction of
3 SDCM ‘‘slices’’, but as described in methods the z stack data set
for each cell is a fully assembled, iteratively deconvolved 3D image
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constructed from approximately 15–20 z slices (see [35] for
additional detail).
(DOC)
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